Download Citation
Article Source:
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Callender T,
Emberton M,
Morris S,
Eeles R,
Kote-Jarai Z,
et al.
(2019)
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study.
PLOS Medicine 16(12): e1002998.
https://doi.org/10.1371/journal.pmed.1002998